Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apoptosis by genetic engineering

J Sinkovics1, J Horvath

  • 1Cancer Institute, St. Joseph's Hospital, Tampa, Florida 33607.

Leukemia
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Malignant cells often evade apoptosis, or programmed cell death. This study explores targeting apoptosis-resistance in tumors using gene therapy and chemotherapy, highlighting challenges in in vivo transfection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

Physical review letters·2024
Same author

Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

Physical review letters·2022
Same author

Validating and assessing the oral health-related quality of life among Hungarian children with cleft lip and palate using Child-OIDP scale.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2020
Same author

The influence of anesthesia on intraoperative neurophysiological monitoring during spinal surgeries.

Bratislavske lekarske listy·2019
Same author

First Report of Impatiens necrotic spot virus in Ornamental Plants in Hungary.

Plant disease·2019
Same author

Investigation of Lake Hévíz Mineral Water Balneotherapy and Hévíz Mud Treatment in Murine Osteoarthritis and Rheumatoid Arthritis Models.

Evidence-based complementary and alternative medicine : eCAM·2018
Same journal

Evolutionary considerations for risk stratification in TP53-variant myeloproliferative neoplasms.

Leukemia·2026
Same journal

Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.

Leukemia·2026
Same journal

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

Leukemia·2026
Same journal

Redefining light-chain smoldering multiple myeloma: prevalence and progression risk.

Leukemia·2026
Same journal

Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II.

Leukemia·2026
Same journal

Retroperitoneal bulk predicts chylothorax in follicular lymphoma-control requires systemic response.

Leukemia·2026
See all related articles

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Apoptosis, a physiological programmed cell death, is often evaded by malignant cells.
  • Genes regulating apoptosis, such as p53 (promoter) and bcl-2, fes (antagonists), are recognized.
  • Tumor cells resistant to apoptosis can still be eliminated by cytotoxic lymphocytes.

Purpose of the Study:

  • To explore therapeutic strategies for overcoming apoptosis resistance in cancer.
  • To investigate the potential of gene therapy and chemotherapy in inducing tumor cell death.
  • To identify challenges and future directions in targeting apoptosis for cancer treatment.

Main Methods:

  • Review of known apoptosis-regulating genes and their roles in cancer.
  • Discussion of lymphocyte-mediated cytotoxicity and apoptosis-inducing cytokines.

Related Experiment Videos

  • Exploration of chemotherapeutic agents, particularly topoisomerase inhibitors, in inducing apoptosis.
  • Proposal for cloning and in vivo transfection of apoptotic genes into tumor cells.

    • Main Results:

    • Malignant cells frequently acquire resistance to apoptosis, a hallmark of cancer.
    • Growth factor/hormone withdrawal can activate apoptosis in dependent tumor cells.
    • Cytotoxic lymphocytes and apoptosis-inducing cytokines show therapeutic potential.
    • Chemotherapeutics, like topoisomerase inhibitors, can induce apoptosis in tumor cells.

    Conclusions:

    • Synergistic effects between biologicals and chemotherapeutics in inducing apoptosis are promising.
    • In vivo gene transfer of apoptotic genes into tumors is a proposed strategy.
    • Current limitations in in vivo transfection technology and understanding of apoptosis need to be addressed.